P.A.W. Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,560
Closed -$182K 61
2020
Q1
$182K Sell
1,560
-2,440
-61% -$285K 0.25% 59
2019
Q4
$764K Buy
+4,000
New +$764K 0.81% 28